Insiders · Profile

Breen Michael Martin

Director at Prairie Operating · Executive Chairman/Interim CEO at GT Biopharma. Filing since 11 Apr 2023. CIK 0001863633

Company
Date
Role
Action
Shares
Amount
Of holding
3 May 2023
Director
Bought
916,112
$99.86K
×92
11 Apr 2023
Executive Chairman/Interim CEO
Bought
50,000
$25.00K
8.2%
2 decisions on file.